Serveur d'exploration COVID et hydrochloroquine - Exploration (Accueil)

Index « Titre (en) » - entrée « tocilizumab »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
toc < tocilizumab < today  Facettes :

List of bibliographic references indexed by tocilizumab

Number of relevant bibliographic references: 34.
[0-20] [0 - 20][0 - 34][20-33][20-40]
Ident.Authors (with country if any)Title
000026 (2021) M. Bovet [Allemagne] ; D. Wadsack [Allemagne] ; F. Kosely [Allemagne] ; W. Zink [Allemagne] ; R. Zahn [Allemagne][Fatal course of COVID-19 despite IL-6 receptor blockade in cytokine storm : Perimyocarditis and coagulopathy after administration of tocilizumab].
000071 (2021) Matt G. Mckenzie [États-Unis] ; Yeunju Michelle Lee [États-Unis] ; Julin Mathew [États-Unis] ; Megan Anderson [États-Unis] ; Alison T. Vo [États-Unis] ; Samuel Akinyele [États-Unis] ; Malarvizhi Narayanan [États-Unis]Tocilizumab for the Critically Ill With Severe COVID-19: A Community Hospital Case Series.
000152 (2021) Inés Jiménez-Lozano [Espagne] ; José Manuel Caro-Teller [Espagne] ; Nuria Fernández-Hidalgo [Espagne] ; Marta Miarons [Espagne] ; Marie Antoinette Frick [Espagne] ; Emma Batllori Badia [Espagne] ; Berta Serrano [Espagne] ; Carlos Javier Parramon-Teixid [Espagne] ; Fátima Camba-Longueira [Espagne] ; Maria Teresa Moral-Pumarega [Espagne] ; Rafael San Juan-Garrido [Espagne] ; Maria Josep Caba As Poy [Espagne] ; Anna Suy [Espagne] ; Maria Queralt Gorgas Torner [Espagne]Safety of tocilizumab in COVID-19 pregnant women and their newborn: A retrospective study.
000296 (2021) Victoria Birlutiu ; Rares Mircea Birlutiu ; Liana Chicea [Roumanie]Off-label tocilizumab and adjuvant iron chelator effectiveness in a group of severe COVID-19 pneumonia patients: A single center experience.
000547 (2021) Steven M. Smoke [États-Unis] ; Karan Raja [États-Unis] ; Patrick Hilden [États-Unis] ; Nicole M. Daniel [États-Unis]Early clinical outcomes with tocilizumab for severe COVID-19: a two-centre retrospective study.
000777 (2021) Theerachai Thammathiwat [Thaïlande] ; Somkanya Tungsanga [Thaïlande] ; Kanitha Tiankanon [Thaïlande] ; Pattama Torvorapanit [Thaïlande] ; Worawat Chumpangern [Thaïlande] ; Suwasin Udomkarnjananun [Thaïlande] ; Yingyos Avihingsanon [Thaïlande] ; Thitiwat Sriprasart [Thaïlande] ; Nattachai Srisawat [Thaïlande] ; Kamonwan Jutivorakool [Thaïlande] ; Leilani Paitoonpong [Thaïlande] ; Opass Putcharoen [Thaïlande] ; Natavudh Townamchai [Thaïlande]A case of successful treatment of severe COVID-19 pneumonia with favipiravir and tocilizumab in post-kidney transplant recipient.
000A07 (2020) Jared Radbel [États-Unis] ; Navaneeth Narayanan [États-Unis] ; Pinki J. Bhatt [États-Unis]Use of Tocilizumab for COVID-19-Induced Cytokine Release Syndrome: A Cautionary Case Report.
000A46 (2020) Faryal Farooqi [États-Unis] ; Naveen Dhawan ; Richard Morgan [États-Unis] ; John Dinh [États-Unis] ; Kester Nedd [États-Unis] ; George Yatzkan [États-Unis]Treatment of Severe COVID-19 with Tocilizumab Mitigates Cytokine Storm and Averts Mechanical Ventilation During Acute Respiratory Distress: A Case Report and Literature Review.
000A61 (2020) Hernando Trujillo [Espagne] ; Fernando Caravaca-Fontán [Espagne] ; Ángel Sevillano [Espagne] ; Eduardo Gutiérrez [Espagne] ; Mario Fernández-Ruiz [Espagne] ; Francisco L Pez-Medrano [Espagne] ; Ana Hernández [Espagne] ; José María Aguado [Espagne] ; Manuel Praga [Espagne] ; Amado Andrés [Espagne]Tocilizumab use in Kidney Transplant Patients with COVID-19.
000A62 (2020) Giovanni Guaraldi [Italie] ; Marianna Meschiari [Italie] ; Alessandro Cozzi-Lepri [Royaume-Uni] ; Jovana Milic [Italie] ; Roberto Tonelli [Italie] ; Marianna Menozzi [Italie] ; Erica Franceschini [Italie] ; Gianluca Cuomo [Italie] ; Gabriella Orlando [Italie] ; Vanni Borghi [Italie] ; Antonella Santoro [Italie] ; Margherita Di Gaetano [Italie] ; Cinzia Puzzolante [Italie] ; Federica Carli [Italie] ; Andrea Bedini [Italie] ; Luca Corradi [Italie] ; Riccardo Fantini [Italie] ; Ivana Castaniere [Italie] ; Luca Tabbì [Italie] ; Massimo Girardis [Italie] ; Sara Tedeschi [Italie] ; Maddalena Giannella [Italie] ; Michele Bartoletti [Italie] ; Renato Pascale [Italie] ; Giovanni Dolci [Italie] ; Lucio Brugioni [Italie] ; Antonello Pietrangelo [Italie] ; Andrea Cossarizza [Italie] ; Federico Pea [Italie] ; Enrico Clini [Italie] ; Carlo Salvarani [Italie] ; Marco Massari [Italie] ; Pier Luigi Viale [Italie] ; Cristina Mussini [Italie]Tocilizumab in patients with severe COVID-19: a retrospective cohort study.
000A63 (2020) John P. Knorr [États-Unis] ; Veronika Colomy [États-Unis] ; Christine M. Mauriello [États-Unis] ; Seung Ha [États-Unis]Tocilizumab in patients with severe COVID-19: A single-center observational analysis.
000A64 (2020) Tariq Kewan [États-Unis] ; Fahrettin Covut [États-Unis] ; Mohammed J. Al-Jaghbeer [États-Unis] ; Lori Rose [États-Unis] ; K V Gopalakrishna [États-Unis] ; Bassel Akbik [États-Unis]Tocilizumab for treatment of patients with severe COVID-19: A retrospective cohort study.
000A65 (2020) Manoon Surabotsophon ; Yingyot Klai-On ; Vipa Thanachartwet ; Sirote Khunapornphairote ; Supat Chamnanchanunt ; Theerapat Racharak ; Wannada Laisuan ; Duangjai Sahassananda ; Samlee Hapunna ; Somjit Jinapuk ; Suthee Leelasetakul ; Varunee DesakornTocilizumab for treating severe COVID-19 pneumonia refractory to combined hydroxychloroquine, lopinavir plus ritonavir, and favipiravir: A case series.
000A66 (2020) Timothy A. West [Australie] ; Sameer Malik [Australie] ; Anastasios Nalpantidis [Australie] ; Tuan Tran [Australie] ; Christine Cannon [Australie] ; Deepak Bhonagiri [Australie] ; Kevin Chan [Australie] ; Elaine Cheong [Australie] ; Jenny Wan Sai Cheong [Australie] ; Winston Cheung [Australie] ; Faisal Choudhury [Australie] ; David Ernest [Australie] ; Claude S. Farah [Australie] ; Shelanah Fernando [Australie] ; Rupa Kanapathipillai [Australie] ; Mark Kol [Australie] ; Brendan Murfin [Australie] ; Haider Naqvi [Australie] ; Asim Shah [Australie] ; Atul Wagh [Australie] ; Samar Ojaimi [Australie] ; Bradley Frankum [Australie] ; Sean Riminton [Australie] ; Karuna Keat [Australie]Tocilizumab for severe COVID-19 pneumonia: Case series of 5 Australian patients.
000A67 (2020) Marta Colaneri [Italie] ; Laura Bogliolo [Italie] ; Pietro Valsecchi [Italie] ; Paolo Sacchi [Italie] ; Valentina Zuccaro [Italie] ; Fabio Brandolino [Italie] ; Carlomaurizio Montecucco [Italie] ; Francesco Mojoli [Italie] ; Emanuele Maria Giusti [Italie] ; Raffaele Bruno [Italie] ; The Covid Irccs San Matteo Pavia Task Force [Italie]Tocilizumab for Treatment of Severe COVID-19 Patients: Preliminary Results from SMAtteo COvid19 REgistry (SMACORE).
000A68 (2020) Malgorzata Mikulska [Italie] ; Laura Ambra Nicolini [Italie] ; Alessio Signori [Italie] ; Antonio Di Biagio [Italie] ; Chiara Sepulcri [Italie] ; Chiara Russo [Italie] ; Silvia Dettori [Italie] ; Marco Berruti [Italie] ; Maria Pia Sormani [Italie] ; Daniele Roberto Giacobbe [Italie] ; Antonio Vena [Italie] ; Andrea De Maria [Italie] ; Chiara Dentone [Italie] ; Lucia Taramasso [Italie] ; Michele Mirabella [Italie] ; Laura Magnasco [Italie] ; Sara Mora [Italie] ; Emanuele Delfino [Italie] ; Federica Toscanini [Italie] ; Elisa Balletto [Italie] ; Anna Ida Alessandrini [Italie] ; Federico Baldi [Italie] ; Federica Briano [Italie] ; Marco Camera [Italie] ; Ferdinando Dodi [Italie] ; Antonio Ferrazin [Italie] ; Laura Labate [Italie] ; Giovanni Mazzarello [Italie] ; Rachele Pincino [Italie] ; Federica Portunato [Italie] ; Stefania Tutino [Italie] ; Emanuela Barisione [Italie] ; Bianca Bruzzone [Italie] ; Andrea Orsi [Italie] ; Eva Schenone [Italie] ; Nirmala Rosseti [Italie] ; Elisabetta Sasso [Italie] ; Giorgio Da Rin [Italie] ; Paolo Pelosi [Italie] ; Sabrina Beltramini [Italie] ; Mauro Giacomini [Italie] ; Giancarlo Icardi [Italie] ; Angelo Gratarola [Italie] ; Matteo Bassetti [Italie]Tocilizumab and steroid treatment in patients with COVID-19 pneumonia.
000A69 (2020) Gaetano Serviddio [Italie] ; Rosanna Villani [Italie] ; Giovanni Stallone [Italie] ; Giulia Scioscia [Italie] ; Maria Pia Foschino-Barbaro [Italie] ; Donato Lacedonia [Italie]Tocilizumab and liver injury in patients with COVID-19.
000B94 (2020) Andrea Lauterio [Italie] ; Mila Valsecchi [Italie] ; Sara Santambrogio [Italie] ; Riccardo De Carlis [Italie] ; Marco Merli [Italie] ; Angelo Calini [Italie] ; Leonardo Centonze [Italie] ; Vincenzo Buscemi [Italie] ; Maurizio Bottiroli [Italie] ; Massimo Puoti [Italie] ; Roberto Fumagalli [Italie] ; Luciano De Carlis [Italie]Successful recovery from severe COVID-19 pneumonia after kidney transplantation: The interplay between immunosuppression and novel therapy including tocilizumab.
000D54 (2020) Juan David Cala-García [Colombie] ; Juan David Sierra-Bret N [Colombie] ; Jorge Eduardo Cavelier-Baiz [Colombie] ; Álvaro A. Faccini-Martínez [Colombie] ; Carlos Eduardo Pérez-Díaz [Colombie]Recovery of COVID-19 acute respiratory distress syndrome with tocilizumab: successful outcome in two critically ill patients.
000D69 (2020) Gonzalo De Luna [France] ; Anoosha Habibi [France] ; Jean-François Deux [France] ; Martin Colard [France] ; Anne-Laure Pham Hung D'Alexandry D'Orengiani [France] ; Frédéric Schlemmer [France] ; Nizar Joher [France] ; Christian Kassasseya [France] ; Jean Michel Pawlotsky [France] ; Clément Ourghanlian [France] ; Marc Michel [France] ; Armand Mekontso-Dessap [France] ; Pablo Bartolucci [France]Rapid and severe Covid-19 pneumonia with severe acute chest syndrome in a sickle cell patient successfully treated with tocilizumab.
000E24 (2020) Anne Lohse [France] ; Timothée Klopfenstein [France] ; Jean-Charles Balblanc [France] ; Pierre-Yves Royer [France] ; Marie Bossert [France] ; Vincent Gendrin [France] ; Aline Charpentier [France] ; Ana-Maria Bozgan [France] ; Julio Badie [France] ; Charlotte Bourgoin [France] ; Remy Contreras [France] ; Isabelle Mazurier [France] ; Thierry Conrozier [France] ; Souheil Zayet [France]Predictive factors of mortality in patients treated with tocilizumab for acute respiratory distress syndrome related to coronavirus disease 2019 (COVID-19).

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "tocilizumab" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "tocilizumab" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    tocilizumab
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021